Here are the latest quarterly results of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES financial fact sheet and DIVIS LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
3
Mar-26* |
3
Jun-26* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 23,380 | 23,190 | 25,850 | 24,100 | 27,150 | 26,040 | 28,310 | 30,800 | |
| Other income | Rs m | 1,060 | 820 | 860 | 1,190 | 1,450 | 880 | 1,550 | 640 | |
| Turnover | Rs m | 24,440 | 24,010 | 26,710 | 25,290 | 28,600 | 26,920 | 29,860 | 31,440 | |
| Expenses | Rs m | 16,220 | 15,760 | 16,990 | 16,810 | 18,270 | 17,140 | 18,970 | 18,250 | |
| Gross profit | Rs m | 7,160 | 7,430 | 8,860 | 7,290 | 8,880 | 8,160 | 9,340 | 12,550 | |
| Depreciation | Rs m | 990 | 990 | 1,070 | 1,120 | 1,130 | 1,180 | 1,200 | 1,330 | |
| Interest | Rs m | 10 | 0 | 10 | 30 | 80 | 60 | 60 | 60 | |
| Profit before tax | Rs m | 7,220 | 7,260 | 8,640 | 7,330 | 9,120 | 7,800 | 9,630 | 11,800 | |
| Tax | Rs m | 2,120 | 1,370 | 2,020 | 1,880 | 2,230 | 1,970 | 2,120 | 2,780 | |
| Profit after tax | Rs m | 5,100 | 5,890 | 6,620 | 5,450 | 6,890 | 5,830 | 7,510 | 9,020 | |
| Gross profit margin | % | 30.6 | 32.0 | 34.3 | 30.2 | 32.7 | 31.3 | 33.0 | 40.7 | |
| Effective tax rate | % | 29.4 | 18.9 | 23.4 | 25.6 | 24.5 | 25.3 | 22.0 | 23.6 | |
| Net profit margin | % | 21.8 | 25.4 | 25.6 | 22.6 | 25.4 | 22.4 | 26.5 | 29.3 | |
| Diluted EPS | Rs | 19.2 | 22.2 | 24.9 | 20.5 | 26.0 | 22.0 | 28.3 | 34.0 | |
| Diluted EPS (TTM) | Rs | 69.2 | 77.9 | 82.5 | 86.9 | 93.6 | 93.4 | 96.7 | 110.2 | |
Although the benchmark indices opened higher, they traded positive throughout the session and ultimately closed green.